Drugmakers Can't Appeal Remand of Darvocet Suits: 6th Circ.

By Hannah Sheehan (November 18, 2015, 7:59 PM EST) -- The Sixth Circuit on Tuesday said Endo Pharmaceuticals and others cannot appeal a Kentucky federal judge's recommendation to remand cases alleging they failed to warn customers of risks associated with Darvocet and other painkillers containing propoxyphene to California federal courts, saying it would not expedite a resolution....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!